Profile data is unavailable for this security.
About the company
PT Phapros Tbk is an Indonesia-based pharmaceutical company. The Company's business pillars consist of branded/ethical prescription medicines: hospitals and pharmacies in addition to other healthcare institutions; over-the-counter drugs: pharmacies, retail; generic prescription drugs: government institutions and hospitals; toll-in manufacturing, and medical device. It offers medicines for cardiovascular and hematopoietic, gastrointestinal and hepatobiliary, hormone Genito, urinary endocrine and metabolic, vitamins and minerals nutrition, dermatology, local anesthesia, immune & allergy, and others. The Company's medical devices include ACS MB system, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho and NPC-STRIP G. Its branded drugs include Colkatriol 0.25 mcg 30 Cap, Diafac XR, Diafac 500 mg 10 tablets, Spirolactone 25 & 1, Dextamine Syrup 60 ml, Diapros Tablet, Proinfarction, anemone, Pladel, and others. The Company also operates calibration laboratory.
- Revenue in IDR (TTM)924.20bn
- Net income in IDR-28.19bn
- Incorporated--
- Employees1.45k
- LocationPhapros Tbk PTLantai Dasar, Gedung RNIJl. Denpasar Raya Kav. DIIIKuninganJAKARTA SELATAN 12950IndonesiaIDN
- Phone+62 215762709
- Fax+62 215763910
- Websitehttps://www.phapros.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Atect Corp | 328.19bn | -25.25bn | 314.52bn | 96.00 | -- | 1.72 | 8.81 | 0.9584 | -55.27 | -55.27 | 718.38 | 398.84 | 0.5895 | 3.30 | 6.85 | -- | -4.54 | 0.7132 | -6.41 | 0.9718 | 43.40 | 47.04 | -7.69 | 1.32 | 0.6992 | -- | 0.5902 | 84.76 | 7.23 | 1.45 | -253.71 | -- | -23.49 | 0.00 |
Nova Organic PCL | 255.72bn | -38.99bn | 319.49bn | 295.00 | -- | -- | -- | 1.25 | -0.1529 | -0.1529 | 1.00 | -- | 0.395 | 3.12 | 13.42 | -- | -6.04 | 13.70 | -6.62 | 16.90 | 40.69 | 61.59 | -15.29 | 14.89 | 6.00 | -- | 0.0087 | -- | -13.76 | 13.37 | 19.45 | -- | 44.73 | -- |
Cannasouth Ltd | 9.46bn | -87.18bn | 320.55bn | -- | -- | 0.6699 | -- | 33.89 | -0.0352 | -0.0353 | 0.0044 | 0.1463 | 0.026 | 1.67 | 3.33 | -- | -23.95 | -25.58 | -26.28 | -27.74 | -127.65 | -- | -921.78 | -1,678.99 | 1.06 | -80.14 | 0.0913 | -- | 579.62 | -- | -11.15 | -- | -- | -- |
Bal Pharma Ltd | 657.70bn | 14.33bn | 321.44bn | -- | 22.29 | 2.39 | 9.46 | 0.4887 | 4.71 | 4.71 | 222.76 | 43.85 | 1.07 | 2.06 | 3.50 | -- | 2.35 | 0.5652 | 6.76 | 1.57 | 43.47 | 43.04 | 2.19 | 0.5638 | 0.7219 | 1.41 | 0.6685 | 79.39 | 11.51 | 8.56 | 187.44 | 14.31 | 5.02 | 3.71 |
Ribomic Inc | 0.00 | -105.84bn | 335.80bn | 25.00 | -- | 0.9448 | -- | -- | -28.70 | -28.70 | 0.00 | 94.20 | 0.00 | -- | -- | -- | -25.19 | -30.52 | -26.34 | -31.71 | -- | -- | -- | -1,777.84 | 22.49 | -- | -- | -- | -100.00 | -- | 38.04 | -- | 4.42 | -- |
BCAL Diagnostics Ltd | 39.17bn | -53.28bn | 336.21bn | -- | -- | 5.18 | -- | 8.58 | -0.0227 | -0.0227 | 0.0166 | 0.0241 | 0.4493 | -- | 3.21 | -- | -61.10 | -54.01 | -67.83 | -62.57 | -- | -- | -136.00 | -248.64 | -- | -131.83 | 0.1985 | -- | 298.63 | 63.18 | -49.51 | -- | 91.62 | -- |
Invion Ltd | 47.54bn | -15.97bn | 342.46bn | 8.00 | -- | 1.80 | -- | 7.20 | -0.0002 | -0.0002 | 0.0007 | 0.0028 | 0.2345 | -- | 3.20 | -- | -7.88 | -16.93 | -8.12 | -18.13 | -- | -- | -33.60 | -51.63 | -- | -- | 0.00 | -- | 25.72 | 41.18 | 27.95 | -- | -- | -- |
Phapros Tbk PT | 924.20bn | -28.19bn | 344.40bn | 1.45k | -- | 0.4783 | 16.95 | 0.3727 | -33.56 | -33.56 | 1,100.24 | 857.25 | 0.5249 | 1.60 | 1.80 | 627,001,100.00 | -1.60 | 2.07 | -2.75 | 4.04 | 49.43 | 51.79 | -3.04 | 3.68 | 0.8243 | 0.4328 | 0.5027 | -- | -13.21 | -0.1734 | -78.77 | -46.21 | -24.81 | -- |